RBD-3045

N/A

Report date: 2025/04/11 14:13:28
NME

Base Information

Drug NameRBD-3045
Drug Alias NameRBD-3045SR045SR-045
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiopoietin like 3 inhibitorsAsialoglycoprotein receptor modulators
TargetsAngiopoietin like 3Asialoglycoprotein receptor
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Ribo Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Ribo Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A